Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.51T | 33.3x | 1.83 | SEK 1,622 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.5% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 108.39B | 27.8x | 0.54 | SEK 315.60 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Getinge B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 58.01B | 35.7x | -1.1 | SEK 213 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.4% Upside | Upgrade to Pro+ | |
Sectra | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 45.56B | 117.8x | -9.35 | SEK 236.45 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 38.99B | 89.8x | -22.76 | SEK 665 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Medicover | Stockholm | Healthcare | Healthcare Providers & Services | SEK 31.38B | 168.3x | -30.72 | SEK 209 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.4% Upside | Upgrade to Pro+ | |
Vitrolife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 26.67B | 52x | 0.46 | SEK 197 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 25.41B | 189.6x | -4.11 | SEK 385.80 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
Elekta B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 22.56B | 21.6x | -0.79 | SEK 59.05 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.4% Upside | Upgrade to Pro+ | |
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 21.62B | -122.4x | 0.69 | SEK 244.60 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 21.11B | 111.4x | 1.22 | SEK 40.35 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.4% Upside | Upgrade to Pro+ | |
AddLife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 19.92B | 78.9x | 2.46 | SEK 163.50 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.5% Upside | Upgrade to Pro+ | |
Xvivo Perfusion AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 13.99B | 81.1x | 1.05 | SEK 444 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.1% Upside | Upgrade to Pro+ | |
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 12.59B | 35.8x | -9.17 | SEK 124.50 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.5% Upside | Upgrade to Pro+ | |
Arjo | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 10.67B | 21.4x | 5.71 | SEK 39.18 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.7% Upside | Upgrade to Pro+ | |
Implantica AG | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 10.02B | -42.3x | -22.14 | SEK 35.40 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47% Upside | Upgrade to Pro+ | |
Attendo International publ AB | Stockholm | Healthcare | Healthcare Providers & Services | SEK 9.47B | 21.7x | 0.94 | SEK 62.50 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ | |
Ambea | Stockholm | Healthcare | Healthcare Providers & Services | SEK 9.32B | 15.4x | 0.36 | SEK 111.10 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
Biotage AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 8.93B | 31.4x | 4.78 | SEK 111.50 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39% Upside | Upgrade to Pro+ | |
RaySearch Labs B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 8.59B | 42x | 0.28 | SEK 250.50 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.8% Upside | Upgrade to Pro+ | |
Surgical Science Sweden | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 8.04B | 61x | -1.39 | SEK 157.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.2% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 6.75B | 68.4x | 1 | SEK 42.50 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.1% Upside | Upgrade to Pro+ | |
CellaVision AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 4.21B | 30x | 3.74 | SEK 176.60 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.9% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.71B | -14.7x | -0.23 | SEK 47.54 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.8% Upside | Upgrade to Pro+ | |
Medistim ASA | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.80B | 28.2x | SEK 149.58 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
BICO Group | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.61B | -1.5x | -0.29 | SEK 36.64 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Humana | Stockholm | Healthcare | Healthcare Providers & Services | SEK 2.44B | 16.4x | -0.77 | SEK 47.05 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.3% Upside | Upgrade to Pro+ | |
Medivir B | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.35B | -0.06 | SEK 1.88 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Stille AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.12B | 36.4x | 1.66 | SEK 236 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.3% Upside | Upgrade to Pro+ | |
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.09B | -34.9x | 2.57 | SEK 126 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.4% Upside | Upgrade to Pro+ | |
Sedana Medical | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.86B | -173.3x | -2.13 | SEK 18.70 | 6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.3% Upside | Upgrade to Pro+ | |
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.86B | -6.7x | -0.18 | SEK 7.92 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.83B | -4.3x | 0.15 | SEK 27.80 | 9.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.80B | -4.5x | -0.27 | SEK 5.02 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genovis AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.79B | 54.9x | -1.17 | SEK 27.40 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.1% Upside | Upgrade to Pro+ | |
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.78B | -2x | -0.12 | SEK 26.18 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carasent AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.73B | -12.86 | SEK 23.94 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5% Upside | Upgrade to Pro+ | ||
SyntheticMR | Spotlight | Healthcare | Healthcare Equipment & Supplies | SEK 1.65B | -10.9x | 0.06 | SEK 4.24 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.53B | -20.5x | 0.21 | SEK 5.42 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OssDsign | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.34B | -24.3x | -0.39 | SEK 13.68 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5% Downside | Upgrade to Pro+ | |
Bactiguard Holding AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.30B | -43.5x | -0.55 | SEK 37 | 7.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.4% Upside | Upgrade to Pro+ | |
Paxman | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.27B | 31.6x | 0.08 | SEK 67 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.9% Upside | Upgrade to Pro+ | |
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.18B | -3.7x | 0.15 | SEK 31.70 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.17B | 15.7x | 0.15 | SEK 41.30 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanoform Finland Plc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.10B | -4.1x | 1.47 | SEK 14.16 | 8.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C-Rad | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.10B | 19.6x | 0.33 | SEK 32.75 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.6% Upside | Upgrade to Pro+ | |
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.04B | -6.1x | 0.66 | SEK 10 | -36.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynAct Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 915.98M | -8.1x | -0.16 | SEK 18.69 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13.3% Downside | Upgrade to Pro+ | |
Nykode Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 821.50M | -1.9x | SEK 13.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Saniona AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 777.60M | 3.9x | -0.34 | SEK 6.91 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |